Press Releases

May 16, 2022

VIVO Cannabis Announces First Quarter 2022 Results

Net revenue for Q1 2022 was $6.9 million VIVO continues to pursue its international expansion strategy which now represents >50% of cannabis revenue Canadian Launch of Canna Farms Single-strain Oils, Infused Pre-rolls, Top Cola Signature Series and Fireside CBD Canna Bliss 510 Vape Cartridge and 10 pack CBD Chocolates Harvest Medicine study on medical cannabis […]

Read More

March 31, 2022

VIVO Cannabis Announces Fourth Quarter 2021 Results

Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million. In February 2021, closed a $7.2 million equity raise to help fund VIVO’s growth In July 2021, the Company elected a new Board of Directors, announced the appointment of Ray Laflamme as CEO and Chairman of the Board and later […]

Read More

February 11, 2022

VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace

Toronto, Ontario–(Newsfile Corp. – February 11, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today announced a partnership with […]

Read More

December 21, 2021

VIVO Cannabis(TM) Announces Appointment of Former President and CEO of Zenabis Global, and Former CFO of Cronos Group, to the Board

Toronto, Ontario–(Newsfile Corp. – December 21, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) is pleased to announce the appointment of Shai Altman and Glen Huber to the board of directors of the Company (the “Board“), effective immediately. “I am very pleased to welcome Mr. Altman and Mr. Huber to […]

Read More

November 23, 2021

VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program

Toronto, Ontario–(Newsfile Corp. – November 23, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today announced the launch of its […]

Read More

November 19, 2021

VIVO Cannabis(TM) Supports Patients and Hope Community During BC Flooding

Toronto, Ontario–(Newsfile Corp. – November 19, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today provided an update on […]

Read More

November 15, 2021

VIVO Cannabis(TM) Announces Third Quarter 2021 Results

Net revenue $6.2 million Net loss reduced to $1.1 million; EBITDA loss reduced to $2.1 million First shipment to Germany completed; Australia sales $2.2 million Toronto, Ontario–(Newsfile Corp. – November 15, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“) today released its third quarter 2021 financial and operating results. Management […]

Read More

November 3, 2021

VIVO Cannabis(TM) Announces Launch of New Lumina(TM) Products

Toronto, Ontario–(Newsfile Corp. – November 3, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today announced the launch of new […]

Read More

October 21, 2021

VIVO Cannabis(TM) Completes First Shipment of EU-GMP Medical Grade Cannabis to Beacon Medical Germany GmbH

Toronto, Ontario–(Newsfile Corp. – October 21, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading medical cannabis company and holder of licenses under the Cannabis Act through its wholly owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc. (“ABcann Medicinals”), today announced that its EU-GMP licensed subsidiary ABcann […]

Read More

October 6, 2021

VIVO Cannabis(TM) Adds Craft Licensed Producer, Delta 9 to Online Medical Marketplace

Toronto, Ontario–(Newsfile Corp. – October 6, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of premium cannabis products and services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc. (“ABcann”), today announced a partnership with […]

Read More

VIVO is a family of premium brands and businesses, building a world-class cannabis company through the acquisition and development of specialty brands.